Neither number is a diagnosis on its own. They are pattern markers, most useful when both are read side by side, tracked over time, and placed next to antibody testing and how a person actually feels.
Complement is a group of plasma proteins that activate one another in sequence, and C3 sits at the junction where every activation route meets 1. Three routes feed into it. The classical pathway starts when antibody binds its target and recruits C1, which then acts on C4 and C2. The lectin pathway starts when a sugar-binding protein latches onto a microbial surface. The alternative pathway ticks over at a low level all the time, ready to amplify on any surface that does not actively switch it off.
All three build an enzyme that splits C3 into two fragments 1. One fragment coats the target so immune cells can grab it. The other is a small signalling molecule that recruits inflammatory cells. From there the cascade continues towards C5 and the membrane attack complex, the pore-forming end stage.
C3 is the most abundant complement protein in serum, and most of it is produced by the liver. Beyond defence against microbes, complement helps clear immune complexes and dying cells from the circulation, and it links the fast innate response to the slower antibody response 1.
That biology is the whole reason the blood test exists. When the cascade runs hard for days or weeks, components are consumed faster than the liver can replace them, and the serum concentration falls. Measuring the protein is therefore an indirect read on how busy the system has been.
A standard C3 and C4 test measures how much of each protein is present in a serum sample, not how well the cascade is functioning 2. The measurement is usually made by light-scattering methods on an automated analyser, and results come back in mg/dL or g/L depending on the laboratory.
There is a second family of complement tests that works differently. Functional assays ask whether a whole pathway can run from start to finish. The classical pathway version is often reported as CH50 or total haemolytic complement, which is what people usually mean by complement total, and the alternative pathway version is reported as AH50 2. Because CH50 depends on every component from C1 through C9 being present and working, a very low functional result alongside unremarkable C3 and C4 concentrations can point towards a missing or faulty component further along the chain 2.
Some reports use the label C3c rather than C3. C3 breaks down in stored serum into C3c, a more stable fragment, so a number of laboratories measure C3c and report it against the C3 reference interval. For everyday interpretation the two are read the same way, but it is worth knowing why the name on your report may differ from the name your clinician used.
They are ordered together because the relationship between them carries information that neither value gives alone 3. C4 sits in the classical and lectin pathways only. C3 sits downstream of all three. The combination therefore hints at which part of the system has been active.
When antibody and antigen form immune complexes and switch on the classical pathway, C4 is consumed early and C3 follows, so both values drift down together. When the alternative pathway is doing the work, C4 is spared and C3 falls on its own 3. A low C4 with a preserved C3 is a third pattern, and it can reflect early or mild classical pathway activation, or simply a person's inherited baseline.
There is an important caveat built into this. Complement proteins also rise as part of a general inflammatory response, so a result sitting comfortably inside the reference interval does not rule out ongoing consumption in someone who is inflamed for another reason 3. This is one reason clinicians put more weight on the direction of travel across several draws than on a single snapshot.
Typical adult reference ranges are shown below, and they vary more between laboratories than most people expect. Always read your result against the interval printed on your own report.
| Test | Typical lab reference range | Units | What it reflects |
|---|---|---|---|
| Complement C3 (or C3c) | roughly 80 to 180 | mg/dL | Amount of the central complement protein in serum |
| Complement C4 | roughly 15 to 45 | mg/dL | Amount of the classical and lectin pathway component |
| CH50 (complement total) | method dependent, use the laboratory's own interval | U/mL or equivalent | Whether the classical pathway works end to end |
These are typical laboratory reference ranges, not targets, and they vary by laboratory, assay method, age and sex. Reference intervals are built from a reference population, so a value just outside one is common and does not by itself describe a disease. A value well below the interval, or a value that has dropped substantially from your own previous result, is the kind of finding worth discussing with a clinician.
A low complement level, called hypocomplementaemia, can arise in three broad ways, consumption by an ongoing immune reaction, reduced production, or an inherited deficiency of a component 3. Sorting between them is the clinician's job, and it usually needs the pattern of C3 against C4, the clinical picture and repeat testing.
Consumption is the most common reason in adults being investigated for immune disease. Immune complexes circulating in the blood or deposited in tissue switch on the classical pathway, and the proteins are used faster than they are replaced. Complement is associated with a range of human autoimmune conditions, both as a contributor to tissue injury and as a measurable marker of activity 6.
Systemic lupus erythematosus is the classic setting. Research suggests that C3 and C4 function as biomarkers of disease activity in lupus, with levels falling during active phases and recovering as activity settles 4. Studies suggest that measuring complement activation products, rather than only the parent proteins, may add information about activity in lupus 5.
Reduced production matters too, because the liver makes most circulating complement. Any state that lowers hepatic synthetic capacity can pull the numbers down, which is why liver function tests often sit alongside complement on a request form.
Inherited deficiency is uncommon but real, and it tends to show up as a persistently very low or absent level of one component that does not budge between draws, often with a history of unusual or recurrent infections 3. None of these interpretations can be read off a single number. A low value is an observation, the possible explanations are several, and the next step is a conversation with a clinician who can see the rest of the picture.
A high C3 or C4 is usually a non-specific sign of inflammation rather than a clue to a particular disease. Both proteins behave as acute phase reactants, meaning the liver increases output during infection, injury, surgery and inflammatory flares, so the serum level climbs for reasons that have nothing to do with the complement system itself being the problem.
This has two practical consequences. First, an isolated high value rarely changes what a clinician does, and it is generally interpreted alongside other inflammatory markers and the clinical context. Second, and more usefully, the acute phase effect can hide consumption. Someone with an inflammatory condition may be producing complement faster and using it faster at the same time, and the two can cancel out to produce a result that looks unremarkable. That is why a drop from a person's own prior level can matter even when the new value is still inside the reference range.
Higher readings can also follow a period of weight gain or metabolic stress, since complement proteins participate in the broader inflammatory tone of the body. As with any single marker, the observation points towards further questions rather than an answer.
Complement levels are rarely interpreted in isolation, and in suspected autoimmune disease they are read next to antinuclear and anti-double-stranded-DNA antibody results. Research suggests that, in lupus, falling C3 and C4 together with rising anti-double-stranded-DNA antibodies accompany active disease, particularly where the kidneys are involved 7.
The two tests answer different questions. An antibody test asks whether the immune system is producing a particular self-directed antibody. A complement test asks whether the downstream machinery that those antibodies recruit has been running.
If you are reading your own results, two companion guides are useful background, one on what a positive ana test does and does not establish, and one on the more specific anti dsdna test. The short version is that antibody positivity on its own is common and non-specific, and complement levels help a clinician judge whether anything is actively happening.
None of this amounts to a diagnosis. A pattern of low complement with positive antibodies is a reason for specialist review, not a conclusion a reader should draw at home.
The kidney is one of the organs where complement activity shows up most clearly, because immune complexes trapped in the filtering units switch on the cascade locally. That is why complement testing often appears alongside kidney function tests when inflammation of the kidney is being considered.
In IgA nephropathy, one of the more common forms of primary glomerular disease, research suggests that serum C3 and C4 levels relate to kidney outcomes 8. In lupus, kidney involvement is the setting where complement consumption tends to be most marked, and research suggests that complement measurements track activity in that context 7.
Any persistent change in urine appearance, new swelling around the ankles or eyes, or a rising blood pressure reading is worth raising with a clinician without waiting for the next scheduled blood draw.
Some of the variation between people is inherited rather than acquired, which is why a mildly unusual single reading is not automatically meaningful. C4 is the clearest example. The gene exists in a variable number of copies between individuals, so baseline C4 concentration differs from person to person, and low C4 gene copy number is associated with susceptibility to lupus 7. A person with fewer copies can run a low-normal or slightly low C4 for life without anything being wrong on that day.
C3 varies too. It occurs in common genetic variants that differ in how the protein behaves, and research suggests these differences carry biological and clinical consequences 9.
This is a strong argument for establishing your own baseline while you are well. A single value tells a clinician where you sit against a reference population. A series of values tells them where you sit against yourself, which is far more informative when something changes. It is also why repeating an unexpected result, rather than acting on it immediately, is often the sensible first move.
Several everyday factors move complement results without any immune disease being involved, and knowing them prevents unnecessary worry. The most common are listed below.
Food, hydration and time of day are not major drivers for these particular proteins, which is part of why fasting is generally not required.
It is a standard venous blood draw, usually a single tube, and fasting is generally not needed unless other tests on the same request require it. Results typically come back within a few days, though turnaround depends on whether the sample is run in-house or sent to a reference laboratory.
Preparation matters less for the patient than for the sample. Complement components are labile, and clinical immunology laboratories pay close attention to how quickly serum is separated and whether it is frozen before transport, because degradation in a poorly handled sample can produce a falsely low functional result 2. If a functional assay such as CH50 has been requested, the collection site should know in advance so the tube is handled correctly.
Two practical tips. Mention any recent infection, vaccination or hospital admission when the blood is taken, because it changes how the result reads. And try to use the same laboratory for repeat testing, since the trend is only interpretable when the method stays constant.
Complement is most useful inside a group of tests rather than on its own, because its value lies in pattern recognition. Clinicians commonly request it alongside a full blood count, kidney function, liver tests, and inflammatory markers such as c reactive protein.
The logic is that each test covers a blind spot in the others. A general inflammatory marker shows that something is driving inflammation but not what. Complement narrows the question towards immune complex activity. Antibody tests point at a mechanism. Kidney function tests show whether an organ is being affected right now. Read together, they build a far more defensible picture than any single abnormal number.
This is the case for testing broadly and repeatedly rather than chasing one marker at a time. FitScript's membership covers 150+ biomarkers tested per year, with interpretation from Atlas, its AI health advisor, and any decision about care or treatment belongs to a licensed provider who has reviewed the person.
ESR is a general, non-specific inflammation marker, so it answers a different question from complement and is often reported beside it. FitScript's optimal range for ESR is 0 to 10 mm/hr (0 to 10 mm/hr for men, 0 to 15 mm/hr for women), against a typical laboratory reference range of 0 to 20 mm/hr (0 to 22 mm/hr for men, 0 to 29 mm/hr for women). Optimal ranges are FitScript's optimisation targets, not diagnostic cut-offs. A raised ESR says inflammation is present somewhere, not where or why, which is exactly why it is paired with more specific markers. For what the test is, how it is run and how to read a result in detail, see the ESR guide.
Any complement result outside the laboratory's reference range is worth raising with a clinician, and some situations deserve a prompt conversation rather than a wait-and-see approach. Low C3 with low C4, especially alongside positive antibody results, joint pain, rash, fever or fatigue, is a combination that usually warrants specialist review. The same applies to a clear fall from your own earlier values even when the new number still sits inside the range.
Symptoms that point towards the kidney deserve attention promptly, including frothy or discoloured urine, reduced urine output, new swelling, or an unexplained rise in blood pressure. A persistently very low level that never moves, particularly with a history of unusual or repeated infections, raises a different question about an inherited component deficiency and is also worth investigating 3.
What a reader should not do is dismiss a suboptimal result, or self-interpret one as a disease. Complement values are read in context, and the context includes your history, your examination and your other tests. This article is educational and is not medical advice, so discuss your own results and any question about treatment with a clinician or licensed provider, who is the person able to decide what comes next.
Serial measurement is where these markers earn their keep, because the trend usually says more than any single value. Research suggests that complement levels function as activity biomarkers in lupus, falling during active phases and recovering as activity settles 4, which is why repeat testing at intervals set by the treating clinician is routine in that setting.
Three habits make a trend readable. Use the same laboratory and method where possible, so you are comparing like with like. Record the context of each draw, including any infection, flare or recent illness, because an acute phase rise can distort the comparison. And keep the companion tests consistent, since a complement value moves differently in meaning depending on what the antibody results are doing at the same time.
How often retesting happens is a clinical decision, not a general rule, and it depends on the condition under review, the current level of activity and what else is being monitored. Treatment decisions belong to a licensed provider.
Both are proteins of the complement cascade, but they sit at different points in it. C4 belongs to the classical and lectin routes, while C3 sits downstream of every route. Because of that, the pattern between the two values gives a clinician a clue about which part of the system has been active.
Fasting is generally not required for complement testing itself. You may still be asked to fast if other tests on the same request need it, such as glucose or a lipid profile. Follow the instructions given by the clinic or laboratory that ordered the draw.
CH50, sometimes labelled total haemolytic complement or complement total, is a functional test rather than a protein measurement. It checks whether the classical pathway can run all the way from start to finish. A very low functional result alongside unremarkable C3 and C4 concentrations can prompt a clinician to look for a missing component further down the chain.
No. A single low value is an observation, not a diagnosis, and low complement can occur for several different reasons including infection, reduced liver production and inherited variation. Diagnosis depends on symptoms, examination, antibody results, urine findings and repeat testing. Bring the result to a clinician who can see the whole picture.
Yes. Complement proteins rise as part of the body's general inflammatory response, so a recent or current infection can push values up. That rise can also mask a fall happening at the same time. Mention any recent illness, vaccination or hospital stay when your blood is taken, because it affects how the result reads.
C3 breaks down in stored serum into C3c, a more stable fragment, so some laboratories measure C3c and report it against the C3 reference interval. For everyday interpretation the two are read the same way. The important thing is to compare your value against the range printed on that same report.
There is no single schedule. How often retesting happens depends on the condition being monitored, how active things are and what other tests are being followed. That timing is a clinical decision made by the clinician managing your care, not something to set yourself.
A mildly low C4 on its own is common and often reflects a person's inherited baseline, since the gene exists in a variable number of copies between individuals. It becomes more meaningful if C3 is also low, if antibody or urine tests are abnormal, or if the value has clearly dropped from your own previous level. Any result outside the laboratory range is worth raising with a clinician.